The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma
Joint Authors
Cheng, Shu-Qun
Yu, Liang-He
Li, Nan
Source
International Journal of Hepatology
Issue
Vol. 2011, Issue 2011 (31 Dec. 2011), pp.1-8, 8 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2011-05-30
Country of Publication
Egypt
No. of Pages
8
Main Subjects
Abstract EN
Hepatocellular carcinoma (HCC) is a highly prevalent and lethal cancer worldwide; despite the curative treatment for HCC, the rate of tumor recurrence after hepatectomy remains high.
Tumor recurrence can occur early (<2 years) or late (>2 years) as metastases or de novo tumors.
Several tumor factors were associated with HCC recurrence; high hepatitis B virus (HBV) load is the major risk factor for late recurrence of HCC after resection.
Preoperative antiviral therapy improves liver function, and postoperative reduce HCC recurrence.
In this paper, we focus on antiviral treatment to improve the liver function, prevent recurrence, and lengthen the overall survival for HBV-related HCC.
American Psychological Association (APA)
Yu, Liang-He& Li, Nan& Cheng, Shu-Qun. 2011. The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma. International Journal of Hepatology،Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-470456
Modern Language Association (MLA)
Yu, Liang-He…[et al.]. The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma. International Journal of Hepatology No. 2011 (2011), pp.1-8.
https://search.emarefa.net/detail/BIM-470456
American Medical Association (AMA)
Yu, Liang-He& Li, Nan& Cheng, Shu-Qun. The Role of Antiviral Therapy for HBV-Related Hepatocellular Carcinoma. International Journal of Hepatology. 2011. Vol. 2011, no. 2011, pp.1-8.
https://search.emarefa.net/detail/BIM-470456
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-470456